H-L-MePhe-OMe*HCl

H-L-MePhe-OMe*HCl is a methyl-substituted phenylalanine methyl ester hydrochloride, where the L-stereocenter on the alpha carbon is retained in the chiral amino acid framework and the side chain presents a substituted aryl group suitable for hydrophobic and aromatic recognition. The molecule is present as an amino ester salt, combining a protonated amine (as the hydrochloride) with a methyl ester at the C-terminus, which strongly influences solubility and the chemoselectivity of subsequent transformations. The ester functionality can participate in standard peptide coupling workflows after activation or conversion to a carboxylate equivalent, while the amino group typically requires base-mediated deprotonation or orthogonal protection depending on the coupling strategy. The aryl side chain substitution pattern can also serve as a handle for downstream derivatization, enabling access to peptidomimetic motifs and structure-tunable analog libraries in synthetic and biochemical studies.

1. Peptide Synthesis

H-L-MePhe-OMe*HCl supports peptide building workflows in solid-phase or solution-phase synthesis after converting the methyl ester into a coupling-ready carboxylate equivalent and managing the amino salt state through controlled base treatment. The L-amino acid core provides an alpha-amino functionality for amide bond formation, while the C-terminal methyl ester enables C-terminal capping or controlled activation depending on whether the residue is used as an intermediate or as a protected segment precursor. The hydrochloride form helps define handling behavior during derivatization steps, and the chiral center contributes stereochemical fidelity through the coupling sequence. Downstream incorporation into protected peptide fragments can generate defined analogs for SAR studies and peptide library construction, with the aromatic side chain supporting hydrophobic packing in peptide conformations.

2. Chiral Amino Acid Intermediate

H-L-MePhe-OMe*HCl functions as a chiral amino acid intermediate for stereoselective synthesis of functionalized phenylalanine derivatives and unnatural amino acid analogs. The L-configuration at the alpha carbon provides a stereochemically defined scaffold for subsequent N-protection, ester hydrolysis, or conversion to activated carboxylic acid derivatives used in peptide coupling chemistry. The methyl ester can be transformed into carboxylate or amide forms to tune reactivity and downstream handling, while the substituted phenyl side chain can be carried through multi-step sequences without losing the stereochemical information. Industrial and research settings can employ this intermediate to prepare chiral building blocks used in fine chemical synthesis, peptide analog manufacturing, and process routes requiring consistent stereochemical control.

3. Side-Chain Functionalization

H-L-MePhe-OMe*HCl can be applied to side-chain modification strategies where the substituted aromatic ring enables controlled derivatization for molecular recognition and binding-site mapping. The amino ester salt format allows selective manipulation of the N-terminus and C-terminus, supporting orthogonal protection planning before electrophilic aromatic substitution, cross-coupling, or oxidative transformations that introduce additional functional groups on the aryl ring. The methyl ester provides a temporary C-terminal handle for protecting-group strategies, allowing ester-to-acid conversion or further functional group installation while maintaining the L-chiral center. Resulting aryl-functionalized amino acid derivatives can be incorporated into peptidomimetics, used to generate SAR-focused analog series, and serve as intermediates for downstream conjugation or material-relevant aromatic motifs.

4. Pharmaceutical Intermediate Preparation

H-L-MePhe-OMe*HCl is suitable for pharmaceutical intermediate preparation where amino acid ester chemistry and stereodefined chiral scaffolds are required for constructing peptide-like fragments. The alpha-amino functionality and C-terminal methyl ester can be leveraged to access carboxylate derivatives, amide-coupling partners, and protected amino acid building blocks used in medicinal chemistry synthesis. The hydrochloride salt form supports reproducible handling during intermediate conversion steps, while the aromatic side chain can influence solubility and binding-site interactions in later-stage scaffold assembly. Downstream processing can yield defined residues for peptidomimetic construction, enabling consistent fragment generation for structure-activity relationship studies and synthetic methodology development.

5. Analytical Research Standards

H-L-MePhe-OMe*HCl can serve in analytical research as a stereochemically defined amino acid ester reference for method development and impurity profiling. The combination of an L-amino acid backbone, methyl ester, and hydrochloride salt state produces a distinct chromatographic and mass spectrometric signature that can be used to monitor ester stability, salt formation behavior, and conversion completeness during protected amino acid synthesis. The substituted phenyl side chain contributes characteristic fragmentation patterns, supporting targeted identification in LC-MS workflows and aiding characterization of peptide coupling intermediates. Broader use includes calibration or verification of derivatization steps in amino acid ester hydrolysis/activation sequences, supporting reliable characterization of amino acid derivative intermediates in both research and industrial quality-focused environments.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

3. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. High fat diet and GLP-1 drugs induce pancreatic injury in mice